Specifically, inhibition of ZFAS1 could potentially alleviate myocardial fibrosis in DbCM by inhibiting cardiomyocyte ferroptosis by sponging miR‐150‐5p to activate CCND2. Here, CCND2 is linked to Myocardial fibrosis.